Public Profile

Roemmers

Roemmers, officially known as Laboratorios Roemmers, is a prominent pharmaceutical company headquartered in Argentina. Established in 1921, Roemmers has grown to become a key player in the Latin American pharmaceutical industry, with a strong presence in various operational regions across the continent. Specialising in the development, manufacturing, and marketing of prescription medications, Roemmers is recognised for its commitment to quality and innovation. The company offers a diverse portfolio of products, including generics and branded pharmaceuticals, which are distinguished by their efficacy and safety. With decades of experience, Roemmers has achieved significant milestones, positioning itself as a trusted name in healthcare. Its dedication to research and development has led to numerous accolades, solidifying its reputation as a leader in the pharmaceutical sector.

DitchCarbon Score

How does Roemmers's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

20

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

30

Industry Benchmark

Roemmers's score of 20 is lower than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.

0%

Let us know if this data was useful to you

Roemmers's reported carbon emissions

Roemmers, headquartered in Argentina (AR), currently does not have publicly available carbon emissions data or specific reduction targets. Without concrete figures or commitments, it is unclear how the company is addressing its carbon footprint or contributing to climate action. As the industry increasingly focuses on sustainability, Roemmers may need to establish clear climate commitments and reduction initiatives to align with global standards and expectations.

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Roemmers's primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Roemmers is in AR, which has a medium grid carbon intensity relative to other regions.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Roemmers is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Similar Organizations

Eurofarma

BR
Pharmaceutical Preparation Manufacturing
Updated 1 day ago

Bausch Health Cos

CA
Pharmaceutical Preparation Manufacturing
Updated 1 day ago

Gador S.A.

AR
Pharmaceutical Preparation Manufacturing
Updated 1 day ago

PROCAPS

CO
Pharmaceutical Preparation Manufacturing
Updated 1 day ago

Knight Therapeutics Inc.

CA
Pharmaceutical Preparation Manufacturing
Updated 1 day ago

Pint Pharma GmbH

AT
Pharmaceutical Preparation Manufacturing
Updated 1 day ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers